| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/18/2007 | CA2280130C Lyophilized compositions containing sphingoglycolipid and process for preparing them |
| 12/18/2007 | CA2277377C Controlled release composition |
| 12/18/2007 | CA2268077C 1,3-bis-(n-lactamyl) propane and the pharmaceutical and cosmetic use thereof |
| 12/18/2007 | CA2233042C Specific binding members for human transforming growth factor beta; materials and methods |
| 12/18/2007 | CA2229960C Steroid compounds having contraceptive and anti-osteoporosis activity |
| 12/18/2007 | CA2219070C Methods of preventing breast cancer |
| 12/18/2007 | CA2210076C Enrofloxacin injection or infusion solutions |
| 12/18/2007 | CA2209001C Hydrophobic taxane derivatives |
| 12/15/2007 | CA2591350A1 Antacid and breath freshening composition |
| 12/13/2007 | WO2007143735A2 Polycationic sulfonamides and use thereof |
| 12/13/2007 | WO2007143724A2 Compositions and methods to enhance reverse cholesterol transport |
| 12/13/2007 | WO2007143705A2 Organic compounds |
| 12/13/2007 | WO2007143694A2 Macrocyclic oximyl hepatitis c protease inhibitors |
| 12/13/2007 | WO2007143676A2 Epinephrine dosing regimens comprising buccal, lingual or sublingual and injectable dosage forms |
| 12/13/2007 | WO2007143675A2 Methods for buccal, lingual or sublingual dosing regimens of epinephrine for the treatment of allergic emergencies |
| 12/13/2007 | WO2007143674A2 Methods for buccal, lingual or sublingual dosing regimens of epinephrine for the treatment of allergic emergencies |
| 12/13/2007 | WO2007143660A1 Reducing muscle soreness with glucosamine compositions |
| 12/13/2007 | WO2007143631A2 Nutraceutical treatments for diabetic and non-diabetic wound healing |
| 12/13/2007 | WO2007143630A2 Treatment of neurofibromatosis with hsp90 inhibitors |
| 12/13/2007 | WO2007143607A2 Method of treating atrophic vaginitis |
| 12/13/2007 | WO2007143600A2 Sheddase inhibitors combined with cd30-binding immunotherapeutics for the treatment of cd30 positive diseases |
| 12/13/2007 | WO2007143587A1 Drug administration methods |
| 12/13/2007 | WO2007143582A2 Reversal of the suppressive function of specific t cells via toll-like receptor 8 signaling |
| 12/13/2007 | WO2007143568A1 Eyelash applicator and method |
| 12/13/2007 | WO2007143557A2 Compounds and methods for treating mammalian gastrointestinal parasitic infections |
| 12/13/2007 | WO2007143526A2 Substituted tetrahydroimidazonaphthyridines and methods |
| 12/13/2007 | WO2007143521A1 Cyclopropyl fused indolobenzazepine hcv inhibitors |
| 12/13/2007 | WO2007143507A2 Preparation and utility of substituted erythromycin analogs |
| 12/13/2007 | WO2007143483A2 Combination of pazopanib and lapatinib for treating cancer |
| 12/13/2007 | WO2007143468A2 Preparation and utility of substituted imidazopyridine compounds with hypnotic effects |
| 12/13/2007 | WO2007143456A2 Benzimidazol substituted thiophene derivatives with activity on plk |
| 12/13/2007 | WO2007143446A1 Spiro-condensed heterotricyclic compounds as hiv integrase inhibitors |
| 12/13/2007 | WO2007143422A2 Substituted pyridyl amide compounds as modulators of the histamine h3 receptor |
| 12/13/2007 | WO2007143336A2 Use of ractopamine enantiomers |
| 12/13/2007 | WO2007143267A2 Treatment of pain disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine and its formamide |
| 12/13/2007 | WO2007143209A2 Luminescent diketonate polymers |
| 12/13/2007 | WO2007143185A2 Transdermal treatment of tendinopathy using glyceryl trinitrite |
| 12/13/2007 | WO2007143175A2 Combination of ceramide and oxaliplatin for inducing cell death and uses thereof in treating cancer |
| 12/13/2007 | WO2007143164A1 Compositions and methods for ameliorating hyperlipidemia |
| 12/13/2007 | WO2007143163A2 Pharmaceutical compositions for sustained release of phenyephrine |
| 12/13/2007 | WO2007143156A1 Phenylphrine pulsed release formulations and pharmaceutical compositions |
| 12/13/2007 | WO2007143143A2 Composition for enhancing muscle recovery |
| 12/13/2007 | WO2007143099A2 Methods for inhibiting cardiac pai-1 |
| 12/13/2007 | WO2007143096A2 Compounds for treating cancers |
| 12/13/2007 | WO2007143081A2 Therapeutic agents for the treatment of lymphoid malignancies |
| 12/13/2007 | WO2007143066A2 Method for predicting susceptibility to radiation pneumonitis |
| 12/13/2007 | WO2007143061A2 Prednisolone salt formulations |
| 12/13/2007 | WO2007143052A1 Galactosides and thiodigalactosides as inhibitors of pa-il lectin from pseudomonas |
| 12/13/2007 | WO2007143038A1 Method of mediating airway smooth muscle construction due to airway irritation |
| 12/13/2007 | WO2007143023A1 Soluble endoglin compounds and uses thereof for the treatment and prevention of cancer |
| 12/13/2007 | WO2007143014A2 Methods for preparing glutamic acid derivatives and intermediates thereof |
| 12/13/2007 | WO2007142973A1 Cobalamin compositions and methods for treating or preventing mucositis |
| 12/13/2007 | WO2007142942A2 Method of improving wound healing |
| 12/13/2007 | WO2007142929A2 Novel pde4 inhibitors |
| 12/13/2007 | WO2007142924A1 Ibudilast for inhibiting macrophage migration inhibitory factor (mif) activity |
| 12/13/2007 | WO2007142923A1 Mif inhibitors for treating neuropathic pain and associated syndromes |
| 12/13/2007 | WO2007142905A2 1-sulfonylindazolylamine and -amide derivatives as 5-hydroxytryptamine-6 ligands |
| 12/13/2007 | WO2007142904A2 Benzoxazole and benzothiazole derivatives as 5-hydroxytrytamine-6 ligands |
| 12/13/2007 | WO2007142755A2 Purine analogs |
| 12/13/2007 | WO2007142725A2 Combination of gyrase b inhibitors and protein synthesis inhibitors and uses thereof |
| 12/13/2007 | WO2007142707A1 Non-steroidal anti-inflammatory oral powder and liquid preparations for administration to animals |
| 12/13/2007 | WO2007142683A2 Self-assembling monomers and oligomers as surface-modifying endgroups for polymers |
| 12/13/2007 | WO2007142629A1 Compositions containing zinc salts for coating medical articles |
| 12/13/2007 | WO2007142628A1 Stable formulation comprising moisture sensitive drug/s and manufacturing procedure thereof |
| 12/13/2007 | WO2007142585A1 Muscarinic receptor agonists that are effective in the treatment of pain, alzheimer's disease and schizophrenia |
| 12/13/2007 | WO2007142584A1 Muscarinic receptor agonists that are effective in the treatment of pain, alzheimer's disease and schizophrenia |
| 12/13/2007 | WO2007142583A1 Muscarinic receptor agonists that are effective in the treatment of pain, alzheimer's disease and schizophrenia. |
| 12/13/2007 | WO2007142581A1 Combination product for the treatment or prevention of dyslipidaemia |
| 12/13/2007 | WO2007142580A1 Novel method for preparation of ammonium salts of esomeprazole |
| 12/13/2007 | WO2007142577A1 Pyrrolo[3,2-d]pyrimidin-4-one derivative as myeloperoxidase inhibitor |
| 12/13/2007 | WO2007142576A1 2-thioxanthine derivatives acting as mpo-inhibitors |
| 12/13/2007 | WO2007142546A2 Sustained release coated tablet with precisely regulated release profile |
| 12/13/2007 | WO2007142510A1 Modulation of the immune system by inositol phospholipids |
| 12/13/2007 | WO2007142502A1 Method for the synthesis of soluble melanin from precursor amino acids |
| 12/13/2007 | WO2007142392A1 Pharmaceutical composition comprising polysaccharides from angelica gigas nakai for activation of dendritic cells |
| 12/13/2007 | WO2007142349A1 Hair growth composition |
| 12/13/2007 | WO2007142336A1 Gene involved in immortalization of human cancer cell and use thereof |
| 12/13/2007 | WO2007142323A1 Novel indazole derivative having spiro ring structure in side chain |
| 12/13/2007 | WO2007142309A1 Method of screening drug for treating kidney glomerulus |
| 12/13/2007 | WO2007142308A1 Nitrogen-containing heterocyclic compound and thrombopoietin receptor activator |
| 12/13/2007 | WO2007142306A1 Highly water-soluble agave inulin, agave inulin-containing product, agave inulin-origin product and by product and method of producing the same |
| 12/13/2007 | WO2007142304A1 SENSE OLIGONUCLEOTIDE CAPABLE OF CONTROLLING THE EXPRESSION OF iNOS AND COMPOSITION COMPRISING THE SAME |
| 12/13/2007 | WO2007142303A1 Method for controlling the amount of gene product, and agent for controlling the amount of gene product |
| 12/13/2007 | WO2007142297A1 Composition for prevention/treatment of hepatic disease |
| 12/13/2007 | WO2007142295A1 Novel tape preparation |
| 12/13/2007 | WO2007142286A1 Fatigue-reducing agent |
| 12/13/2007 | WO2007142285A1 Method for purification of hyaluronic acid salt |
| 12/13/2007 | WO2007142259A1 2-benzyl-5-(4-chlorophenyl)-6-[4-(methylthio)phenyl]-2h-pyridazine-3-one-containing complex and process for producing the same |
| 12/13/2007 | WO2007142253A1 2-cyanopyrrolidine derivative |
| 12/13/2007 | WO2007142231A1 Agent for improvement in blood fluidity |
| 12/13/2007 | WO2007142217A1 1-phenylpyridone derivative |
| 12/13/2007 | WO2007142212A1 Preparation composition |
| 12/13/2007 | WO2007142158A1 9,10-secopregnane derivative and pharmaceutical |
| 12/13/2007 | WO2007142150A1 Novel aminoglycoside antibiotic |
| 12/13/2007 | WO2007142139A1 Method of identifying candidate for remedy of acute myeloid leukemia |
| 12/13/2007 | WO2007142118A1 Composition for preventing the occurrence of cardiovascular event in multiple risk patient |
| 12/13/2007 | WO2007142028A1 Pyrrolidine analogue for preventing neurogenic pain and method for production thereof |
| 12/13/2007 | WO2007141926A1 Extended amyloid beta production inhibitor |
| 12/13/2007 | WO2007141900A1 Separation method |
| 12/13/2007 | WO2007141898A1 Ameliorant for eye strain |